Literature DB >> 11238611

Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice.

S Seo 1, J Buckler, J Erikson.   

Abstract

Lyn-deficient mice produce Abs against dsDNA, yet exhibit exaggerated tolerance to the model Ag hen-egg lysozyme. To investigate this apparent contradiction, and to further examine the function of Lyn in Ag-engaged cells, we have used an anti-dsDNA Ig transgenic model. Previously, looking at these anti-dsDNA B cells in Lyn-sufficient BALB/c mice, we showed that they are regulated by functional inactivation (anergy). In the absence of Lyn, these anti-dsDNA B cells remain unable to secrete Ab. This suggests that functional inactivation of anti-dsDNA B cells does not depend on Lyn, and that the anti-dsDNA Abs that are produced in lyn(-/-) mice arise from a defect in another mechanism of B cell tolerance. Although the anti-dsDNA B cells remain anergic, Lyn deficiency does restore their ability to proliferate to LPS. This reveals a novel role for Lyn in mediating the LPS unresponsiveness that normally follows surface Ig engagement. Furthermore, Lyn deficiency leads to an altered splenic localization and EBV-induced molecule 1 ligand chemokine responsiveness of anti-dsDNA B cells, as well as an absence of marginal zone B cells, suggesting additional roles for Lyn in controlling the migration and development of specific B cell populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238611     DOI: 10.4049/jimmunol.166.6.3710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.

Authors:  Toni Gutierrez; Jessica M Mayeux; Sterling B Ortega; Nitin J Karandikar; Quan-Zhen Li; Dinesh Rakheja; Xin J Zhou; Anne B Satterthwaite
Journal:  Eur J Immunol       Date:  2012-12-18       Impact factor: 5.532

Review 4.  TLR signaling in B-cell development and activation.

Authors:  Zhaolin Hua; Baidong Hou
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

5.  A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.

Authors:  Anne B Satterthwaite; Wei Luo; Jessica Mayeux; Toni Gutierrez; Lisa Russell; Andrew Getahun; Jennifer Müller; Thomas Tedder; Jane Parnes; Robert Rickert; Lars Nitschke; John Cambier; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Regulation of the B cell receptor repertoire and self-reactivity by BAFF.

Authors:  Miyo Ota; Bao H Duong; Ali Torkamani; Colleen M Doyle; Amanda L Gavin; Takayuki Ota; David Nemazee
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

7.  Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells.

Authors:  Andrew J Gross; Irina Proekt; Anthony L DeFranco
Journal:  Eur J Immunol       Date:  2011-11-10       Impact factor: 5.532

8.  Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development.

Authors:  J Stewart New; Brian L P Dizon; Christopher F Fucile; Alexander F Rosenberg; John F Kearney; R Glenn King
Journal:  Immunity       Date:  2020-06-30       Impact factor: 31.745

Review 9.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

10.  Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.

Authors:  Andrew J Gross; Julia R Lyandres; Anil K Panigrahi; Eline T Luning Prak; Anthony L DeFranco
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.